UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: 3/31/02
-----------------------
Check Here if Amendment / /; Amendment Number:
---------
This Amendment (Check only one.): / / is a restatement.
/ / adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Hambrecht & Quist Capital Management Inc.
-----------------------------------------
Address: 30 Rowes Wharf
-----------------------------------------
Boston, MA 02110
-----------------------------------------
-----------------------------------------
Form 13F File Number: 28-04219
---------------------
The institutional investment manager filing this report and the person by
whom it is signed hereby represent that the person signing the report is
authorized to submit it, that all information contained herein is true,
correct and complete, and that it is understood that all required items,
statements, schedules, lists, and tables, are considered integral parts of
this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kim Carroll
-------------------------------
Title: Treasurer
-------------------------------
Phone: 617-310-0537
-------------------------------
Signature, Place, and Date of Signing:
Kim Carroll Boston, MA 5/9/02
------------------------------- ----------------- -------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
/X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
/ / 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
/ / 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
---------------------------- -------------- --------- ------------ ------------------ -------- -------- ----------------------
VALUE SHARES OR SH/ PUT/ INVSTMNT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
---------------------------- -------------- --------- ------------ --------- --- ---- -------- -------- ------ -------- ------
Abgenix Common 00039B107 $4,722,500 250,000 SOLE NA X
Aradigm Common 038505103 1,273,528 350,000 SOLE NA X
ATS Medical Common 002083103 2,532,727 636,364 SOLE NA X
Biofield Common 090591207 399,883 878,766 SOLE NA X
Biofield (Restricted) Common 090591207 364,000 1,000,000 SOLE NA X
Bioject Medical Technologies Common 09059T206 916,300 238,000 SOLE NA X
Biopure Common 09065H915 1,799,308 169,746 SOLE NA X
BioTransplant Common 09066Y107 4,010,720 712,518 SOLE NA X
Biovail Common 09067K106 13,561,974 271,348 SOLE NA X
Catalytica Energy Systems Common 148884109 433,096 128,515 SOLE NA X
Celgene Common 151020104 17,077,500 690,000 SOLE NA X
Cephalon Common 156708109 5,670,000 90,000 SOLE NA X
Corixa Common 21887F100 2,415,308 391,460 SOLE NA X
Cubist Pharmaceuticals Common 229990981 17,703,933 958,005 SOLE NA X
Curis Common 231269101 323,495 151,500 SOLE NA X
CV Therapeutics Common 126667104 19,776,314 546,307 SOLE NA X
Cytyc Common 232946103 11,690,980 434,286 SOLE NA X
Digene Common 253752109 983,125 27,500 SOLE NA X
Dyax Common 26746E103 2,012,096 546,765 SOLE NA X
Emisphere Technologies Common 291345106 2,568,510 151,000 SOLE NA X
Endocardial Solutions Common 292962107 13,516,661 1,666,666 SOLE NA X
Envirogen Common 294040100 30,625 20,833 SOLE NA X
EP Med Systems Common 26881P103 2,644,315 1,075,000 SOLE NA X
Exelixis Common 30161Q104 6,046,915 438,500 SOLE NA X
Genzyme Common 372917104 11,747,499 269,000 SOLE NA X
Gilead Sciences Common 37555B103 26,151,630 726,636 SOLE NA X
IDEXX Laboratories Common 45168D104 6,710,000 250,000 SOLE NA X
Lexicon Genetics Common 5288872104 1,233,225 130,500 SOLE NA X
Lynx Therapeutics Common 551812308 817,500 375,000 SOLE NA X
Martek Biosciences Common 572901106 24,560,671 780,224 SOLE NA X
MedImmune Common 584699102 12,978,900 330,000 SOLE NA X
Molecular Devices Common 60851C107 5,283,254 290,768 SOLE NA X
Orthovita Common 68750U102 4,165,000 1,700,000 SOLE NA X
Quintiles Transnational Common 748767100 2,713,975 152,900 SOLE NA X
Radiance Medical Systems Common 750241101 412,500 330,000 SOLE NA X
Rigel Pharmaceuticals Common 766559108 3,008,625 847,500
Telik Common 87959M109 8,079,979 666,665 SOLE NA X
Teva Pharmaceutical Industries Common 881624209 5,467,000 100,000 SOLE NA X
Transkaryotic Therapies Common 893735100 16,468,778 382,550 SOLE NA X
Tularik Common 899165104 6,664,858 405,405 SOLE NA X
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
---------------------------- -------------- --------- ------------ ------------------ -------- -------- ----------------------
VALUE SHARES OR SH/ PUT/ INVSTMNT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
---------------------------- -------------- --------- ------------ --------- --- ---- -------- -------- ------ -------- ------
Verdant Brands Common 923366108 228 38,000 SOLE NA X
Versicor Common 925314106 12,600,693 696,941 SOLE NA X
WebMD Common 94769M105 5,164,800 672,500 SOLE NA X
COLUMN TOTALS $286,702,928
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
--------------------
Form 13F Information Table Entry Total: 43
--------------------
Form 13F Information Table Value Total: $ 286,702,928
--------------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.